TY - JOUR
T1 - Corrigendum to ‘Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection
T2 - A case report and review of literature’ (Mult. Scler. Relat. Disord. (2016) 9 (158–162) (S2211034816301250) (10.1016/j.msard.2016.07.015))
AU - Grebenciucova, Elena
AU - Reder, Anthony T.
AU - Bernard, Jacqueline T.
N1 - Publisher Copyright:
© 2016
PY - 2016/11/1
Y1 - 2016/11/1
N2 - The authors regret that there was an error on p. 159, first paragraph of the above article. The words ‘cryptococcal antigen/antigenemia’ should be ‘cryptococcal antibody’ and should be read as following: ‘Different geographic populations may exhibit different levels of antibody positivity (Goldman et al., 2001), A study on pre-solid organ transplant patients showed that cryptococcal antibody positivity prior to the transplant was evident in 52% of patients who later developed active infection and correlated with the risk and timing of development of cryptoccal meningitis post-transplant. Patients who were antibody-positive prior to the transplantation developed cryptococcocal infection significantly earlier after transplant than patients without preexistent antibody positivity (5.6 +/- 3.4 months compared to 40.6 +/- 63.8 months) (Saha et al., 2007)’. The authors would like to apologize for any inconvenience caused.
AB - The authors regret that there was an error on p. 159, first paragraph of the above article. The words ‘cryptococcal antigen/antigenemia’ should be ‘cryptococcal antibody’ and should be read as following: ‘Different geographic populations may exhibit different levels of antibody positivity (Goldman et al., 2001), A study on pre-solid organ transplant patients showed that cryptococcal antibody positivity prior to the transplant was evident in 52% of patients who later developed active infection and correlated with the risk and timing of development of cryptoccal meningitis post-transplant. Patients who were antibody-positive prior to the transplantation developed cryptococcocal infection significantly earlier after transplant than patients without preexistent antibody positivity (5.6 +/- 3.4 months compared to 40.6 +/- 63.8 months) (Saha et al., 2007)’. The authors would like to apologize for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=84992107691&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992107691&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2016.09.010
DO - 10.1016/j.msard.2016.09.010
M3 - Comment/debate
AN - SCOPUS:84992107691
SN - 2211-0348
VL - 10
SP - 213
JO - Multiple sclerosis and related disorders
JF - Multiple sclerosis and related disorders
ER -